Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David S Alberts

Showing results (31-40 of 184) with videos related to

Pageof 19
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 17, 2003
Increase in expression of the copper transporter ATP7A during platinum drug-based treatment is associated with poor survival in ovarian cancer patientsGoli Samimi, Nissi M Varki, Sharon Wilczynski, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 22, 2013
Dietary intake and ovarian cancer risk: a systematic reviewTracy E Crane, Beman R Khulpateea, David S Alberts, et al.
Cancer Research|December 13, 2006
Cancer chemoprevention and cancer preventive vaccines--a call to action: leaders of diverse stakeholder groups present strategies for overcoming multiple barriers to meet an urgent needRonald B Herberman, Homer L Pearce, Scott M Lippman, et al.
Molecular Carcinogenesis|April 30, 2003
Variation in cyclooxygenase expression levels within the colorectumFrederick W Wiese, Patricia A Thompson, James Warneke, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 22, 2002
Modulation of biologic endpoints by topical difluoromethylornithine (DFMO), in subjects at high-risk for nonmelanoma skin cancerJanine G Einspahr, Mark A Nelson, Kathylynn Saboda, et al.
Proceedings of Spie--The International Society for Optical Engineering|July 14, 2015
Quantifying and Reducing Uncertainties in Cancer TherapyHarrison H Barrett, David S Alberts, James M Woolfenden, et al.
Analytical and Quantitative Cytology and Histology|January 13, 2004
A karyometric approach to the characterization of atypical endometrial hyperplasia with and without co-occurring adenocarcinomaFrancisco A Garcia, John R Davis, David S Alberts, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 22, 2006
Pretreatment CA-125 and risk of relapse in advanced ovarian cancerMaurie Markman, P Y Liu, Mace L Rothenberg, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|July 13, 2002
Simultaneous quantitation of fatty acids, sterols and bile acids in human stool by capillary gas-liquid chromatographyAshok K Batta, Gerald Salen, Priti Batta, et al.
Cancer Prevention Research (Philadelphia, Pa.)|November 8, 2011
Risk modification of colorectal adenoma by CYP7A1 polymorphisms and the role of bile acid metabolism in carcinogenesisBetsy C Wertheim, Jeffrey W Smith, Changming Fang, et al.
Pageof 19

Showing results (31-40 of 184) with videos related to

Sort By:
Pageof 19
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 17, 2003
Increase in expression of the copper transporter ATP7A during platinum drug-based treatment is associated with poor survival in ovarian cancer patientsGoli Samimi, Nissi M Varki, Sharon Wilczynski, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 22, 2013
Dietary intake and ovarian cancer risk: a systematic reviewTracy E Crane, Beman R Khulpateea, David S Alberts, et al.
Cancer Research|December 13, 2006
Cancer chemoprevention and cancer preventive vaccines--a call to action: leaders of diverse stakeholder groups present strategies for overcoming multiple barriers to meet an urgent needRonald B Herberman, Homer L Pearce, Scott M Lippman, et al.
Molecular Carcinogenesis|April 30, 2003
Variation in cyclooxygenase expression levels within the colorectumFrederick W Wiese, Patricia A Thompson, James Warneke, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 22, 2002
Modulation of biologic endpoints by topical difluoromethylornithine (DFMO), in subjects at high-risk for nonmelanoma skin cancerJanine G Einspahr, Mark A Nelson, Kathylynn Saboda, et al.
Proceedings of Spie--The International Society for Optical Engineering|July 14, 2015
Quantifying and Reducing Uncertainties in Cancer TherapyHarrison H Barrett, David S Alberts, James M Woolfenden, et al.
Analytical and Quantitative Cytology and Histology|January 13, 2004
A karyometric approach to the characterization of atypical endometrial hyperplasia with and without co-occurring adenocarcinomaFrancisco A Garcia, John R Davis, David S Alberts, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 22, 2006
Pretreatment CA-125 and risk of relapse in advanced ovarian cancerMaurie Markman, P Y Liu, Mace L Rothenberg, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|July 13, 2002
Simultaneous quantitation of fatty acids, sterols and bile acids in human stool by capillary gas-liquid chromatographyAshok K Batta, Gerald Salen, Priti Batta, et al.
Cancer Prevention Research (Philadelphia, Pa.)|November 8, 2011
Risk modification of colorectal adenoma by CYP7A1 polymorphisms and the role of bile acid metabolism in carcinogenesisBetsy C Wertheim, Jeffrey W Smith, Changming Fang, et al.
Pageof 19